ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. they run under a venture philanthropy model, through collaborations and partnerships with non-profit foundations and government agencies in both the US and the EU. As such, we keep the focus on stakeholders rather than stockholders.